CN Patent

CN103274961A — 治疗细胞增殖紊乱的化合物和方法

Assigned to Anzix Special Purpose Co ltd · Expires 2013-09-04 · 13y expired

What this patent protects

本发明涉及的是治疗细胞增殖紊乱的化合物和方法。

USPTO Abstract

本发明涉及的是治疗细胞增殖紊乱的化合物和方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN103274961A
Jurisdiction
CN
Classification
—
Expires
2013-09-04
Drug substance claim
No
Drug product claim
No
Assignee
Anzix Special Purpose Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.